Key facts
- Ketone-IQ’s last known valuation is $50.0M (Jan 2021).
- It has raised $10.4M; the latest was Secondary Transaction - Private in Dec 2025.
- Notable investors include Andreessen Horowitz, Soma Capital, Gaingels, Liquid 2 Ventures, Pareto Holdings — 45 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 45 names
- ·Watchlist + deal alerts for Ketone-IQ
- ·The full record, as it builds
Funding rounds
No funding rounds for Ketone-IQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ketone-IQ
Producer of cognitive supplements intended to quantify, manipulate, and optimize human systems. The company's supplements help to redefine the limits of human performance, metabolism, and longevity, improve memory, and increase energy and focus, enabling consumers to apply edge metabolism and physiology research to support health and performance goals that help to diagnose, treat, cure, or prevent any disease.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Miami, FL, United States
- Founded
- 2014
- Employees
- 45
- Website
- ketone.com/
- Ownership
- Privately Held (backing)
Ketone-IQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ketone-IQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ketone-IQ in its N-PORT filings yet. We sweep new filings monthly.